Back
Intra-Cellular Therapies Stock Predictions

3 A.I.-Predicted Stocks to Add to Your Portfolio
Watch Live & FREE Thriving Trends Forecasted by This A.I. Now
Sell
44
ITCI
Intra-Cellular Therapies
Last Price:
63.22
Seasonality Move:
-4.02%
7 Day Trial
ALL ACCESS PASS
$
7

Five Top Tech Stocks to Own Now
Click Here to Download the FREE ReportIntra-Cellular Therapies Stock Forecast
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 36.2% based on the past 9 years of stock performance.
- Intra-Cellular Therapies has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $61.32. The Score for ITCI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 36.2% based on the past 9 years of stock performance.
Intra-Cellular Therapies Stock Rating
Sell
44
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies overpriced?
- Intra-Cellular Therapies has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Intra-Cellular Therapies Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
66.56
52-Week Low:
42.01
Prediction Charts
Market Cap:
5.88B
Price in USD:
61.32
Volume:
633.41K
Beta:
1.06
Technical Analysis
SMA50:
60.11
SMA100:
53.83
SMA200:
51.82
52-Wk Change:
10.17%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company. -
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 61.32 USD today. -
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-15 | 64.50 | 64.91 | 65.59 | 64.21 |
May-16 | 63.80 | 63.14 | 63.80 | 61.92 |
May-17 | 63.24 | 63.41 | 64.15 | 62.21 |
May-18 | 63.50 | 62.98 | 64.04 | 62.18 |
May-19 | 63.48 | 62.42 | 63.55 | 62.17 |
May-22 | 62.66 | 62.64 | 63.23 | 62.07 |
May-23 | 62.59 | 61.83 | 63.89 | 61.42 |
May-24 | 61.64 | 61.00 | 62.22 | 60.48 |
May-25 | 61.00 | 60.17 | 62.16 | 59.13 |
May-26 | 60.07 | 60.20 | 60.72 | 59.77 |
May-30 | 60.06 | 59.43 | 60.25 | 59.31 |
May-31 | 59.91 | 59.37 | 61.00 | 59.31 |
Jun-1 | 59.28 | 59.53 | 60.46 | 58.33 |
Jun-2 | 60.09 | 61.32 | 61.66 | 59.03 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.39 per share, an increase this year of $0.59 per share, and an increase next year of $1.60 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.